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Abstract: Flavonols and flavanones are polyphenols exerting many healthy biological 
activities. They are often glycosylated by rutinose, which hampers absorption in the small 
intestine. Therefore they require the gut microbiota to release the aglycone and enable colonic 
absorption. The role of the gut microbiota and bifidobacteria in the release of the aglycones 
from two major rutinosides, hesperidin and rutin, was investigated. In bioconversion 
experiments, the microbiota removed rutinose from both rutin and hesperidin, even though 
complete hydrolysis was not obtained. To investigate whether bifidobacteria can participate 
to the hydrolysis of rutinosides, 33 strains were screened. Rutin was resistant to hydrolysis 
by all the strains. Among six tested species, mostly Bifidobacterium catenulatum and 
Bifidobacterium pseudocatenultum were able to hydrolyze hesperidin, by means of a  
cell-associated activity. This result is in agreement with the presence of a putative  
α-L-rhamnosidase in the genome of B. pseudocatenulatum, while most of the available 
genome sequences of bifidobacteria aside from this species do not bear this sequence. Even 
though B. pseudocatenulatum may contribute to the release of the aglycone from certain 
rutinose-conjugated polyphenols, such as hesperidin, it remains to be clarified whether this 
species may exert a role in affecting the bioavailability of the rutinoside in vivo. 
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1. Introduction 
Plants are dietary sources of hundreds of polyphenols with beneficial biological activities. 
Polyphenols are classified as phenolic acids, flavonoids, stilbenes, lignans, hydrolyzable tannins, and 
condensed tannins on the basis of the number of phenol rings and the structure elements which connect 
them, with flavonoids clustered into flavonols, flavones, isoflavones, flavanones, anthocyanidins, and 
flavanols [1]. Likewise other flavonoids, flavonols and flavanones are antioxidants, and exert many 
health effects which include anti-inflammatory effects and protective activities against breast and 
gastrointestinal cancer and cardiovascular diseases [2–4]. 
Flavonols are the most ubiquitous flavonoids in food, particularly in onions, vegetables, berries, wine, 
and tea. Quercetin is the most abundant flavonol, followed by kaempferol. These compounds generally 
occur in glycosylated form, bound to glucose, rhamnose, or rutinose, the most widespread glycosidic 
form of quercetin being its rutinoside, rutin (Figure 1) [1]. Flavanones are less common than flavonols, 
but they are present in particularly high concentrations in citrus fruit, particularly in the albedo. 
Hesperetin, naringenin, and eriodictyol are the most common flavanones. They are generally 
glycosylated by disaccharides, such as rutinose or neohesperidose. The most widespread glycosidic form 
of hesperetin in citrus is the rutinoside, hesperidin (Figure 1) [1]. 
 
Figure 1. Structure of rutinose (A); rutin and quercetin (B); hesperidin and hesperetin (C). 
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The sugar moiety has a major impact on the absorption of flavonols and flavanones in the small 
intestine [5]. Conjugation with glucose enhances quercetin absorption from the small intestine, through 
mechanisms that certainly involve active transport of the glucoside. On the other hand, the other  
glyco-conjugates of quercetin are poorly absorbed in the upper tract of the intestine and reach the hindgut 
where they encounter the resident microbiota. In the colon, bacteria could hydrolyze rutin or other  
glyco-conjugates, thus removing the sugar moiety and enabling the absorption of the aglycone [6–10]. 
As with flavonols, the conjugation to rutinose limits the absorption of flavanones in the small intestine. 
Therefore, the rutinosides of flavanones also require hydrolysis by colonic bacteria to release the 
aglycone, and to enable absorption in the colon [11,12]. 
Among indigenous bacteria of human gut microbiota, the genus Bifidobacterium is the most relevant 
health-promoting group [13]. Bifidobacteria are obligate saccharolytic fermentative bacteria which exert 
beneficial health effects through a variety of different mechanisms [14–16]. It was also hypothesized 
that they may be involved in the release of aglycones from glyco-conjugated forms of polyphenols [17]. 
Having adapted within an ecosystem where indigestible oligo- and polysacchardies are the major 
fermentable carbon source, bifidobacteria bear a number of glycosyl hydrolases that may potentially be 
involved also in the hydrolysis of glyco-conjugate forms of phytochemicals [18,19]. As a matter of fact, 
some species of Bifidobacterium can hydrolyze the soy isoflavones daidzin, the lignan 
secoisolariciresinol-diglucoside, and chlorogenic acid [20–23]. This study aims to focus on the 
involvement of bifidobacteria in the hydrolysis of the major rutinosides rutin and hesperidin, taking into 
account the inter-individual variability of transformation of these conjugated flavonoids by 
colonic microbiota. 
2. Experimental Section 
2.1. Chemicals and Bacterial Strains 
All chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) unless otherwise stated. 
Hesperetin, hesperidin, quercetin, and rutin were dissolved at the concentration of 250 mM in DMSO. 
The stock solutions were diluted in DMSO to prepare the analytical standards. Appropriate volumes 
were added to bioconversion mixtures to achieve 500 μM, this concentration being within the range 
utilized in previous studies with other phytochemicals and consistent with reasonable dietary 
intake [1,21,24]. 
Thirty-three intestinal strains of bifidobacteria were taken from our culture collection or obtained 
from the ATCC (Table 1). All the strains were anaerobically cultured at 37 °C in Lactobacilli MRS broth 
(BD Difco, Sparks, NV, USA) supplemented with 0.5 g/L L-cysteine HCl, hereinafter referred to as 
MRS. Growth was monitored by measuring the turbidity at 600 nm (OD600). 
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Table 1. Hydrolysis of rutin and hesperidin by cultures of Bifidobacterium strains. 
Strain Rutin → Quercetin Hesperidin → Hesperetin 
 Bioconversion % Bioconversion % 
B. animalis subsp. animalis ATCC 27536 - - 
B. animalis subsp. animalis WC 0409 - - 
B. animalis subsp. animalis WC 0410 - - 
B. animalis subsp. animalis WC 0411 - - 
B. animalis subsp. lactis WC 0412 - - 
B. animalis subsp. lactis WC 0413 - - 
B. animalis subsp. lactis WC 0414 - - 
B. animalis subsp. lactis WC 0432 - - 
B. animalis subsp. lactis WC 0471 - - 
B. bifidum WC 0415 - - 
B. bifidum WC 0417 - - 
B. bifidum WC 0418 - - 
B. breve WC 0420 - - 
B. breve WC 0421 - - 
B. breve WC 0422 - 4a 
B. breve WC 0423 - - 
B. breve WC 0424 - - 
B. breve WC 0473 - - 
B. catenulatum ATCC 27539 - 6a 
B. longum subsp. infantis ATCC 15697 - - 
B. longum subsp. infantis WC 0433 - - 
B. longum subsp. infantis WC 0434 - - 
B. longum subsp. longum WC 0436 - - 
B. longum subsp. longum WC 0438 - - 
B. longum subsp. longum WC 0439 - - 
B. longum subsp. longum WC 0440 - - 
B. longum subsp. longum WC 0443 - - 
B. pseudocatenulatum WC 0400 - 9a 
B. pseudocatenulatum WC 0401 - 6a 
B. pseudocatenulatum WC 0402 - - 
B. pseudocatenulatum WC 0403 - 46c 
B. pseudocatenulatum WC 0407 - 5a 
B. pseudocatenulatum WC 0408 - 16b 
Bifidobacteria were cultured for 48 h in MRS supplemented with 500 μM rutinoside. Values are means, n = 3. 
Within a column, means with different letters significantly differ (p < 0.05). “-” indicates the absence of 
detectable hydrolysis products. 
2.2. Bioconversion of Hesperidin and Rutin by Fecal Bacteria 
The fecal specimens that were utilized for bioconversion experiments were collected after obtaining 
written informed consent from nine healthy volunteers (six men and three women, aged 25 to 50) who 
had not been treated with prebiotics and/or probiotics for one month, and antibiotics for at least three 
months. The subjects joined the study voluntarily after being informed of the study (aim, experimental 
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scheme, and expected results), and that they would not be subjected to any treatment, and that personal 
data and specimens would be confidential. 
Feces were suspended 10% w/v in phosphate buffered saline, containing 0.5 g/L L-cysteine HCl (pH 
adjusted to 6.5), hereinafter referred to as PBS-Cys. To perform experiments with reproducible inocula, 
suspensions were supplemented with 100 g/L glycerol and stored at −20 °C until use. Preparation was 
performed in an anaerobic cabinet (Anaerobic System, Forma Scientific, Marietta, OH, USA) under an 
85% N2, 10% CO2, 5% H2 atmosphere. 
For bioconversion experiments, 1 mL of fecal suspension was anaerobically diluted with 4 mL of 
PBS-Cys, and supplemented with 500 μM hesperidin or rutin. The samples were anaerobically incubated 
at 37 °C for 24 h and analyzed for bioconversion yield. Blank controls containing the same nine fecal 
samples incubated for 24 h in PBS-Cys were prepared. As control, 500 μM hesperidin or rutin was 
incubated in PBS buffer for 24 h. 
2.3. Bioconversion of Hesperidin and Rutin by Bifidobacteria 
Overnight cultures of bifidobacteria were inoculated (10% v/v) into 5 mL of MRS supplemented with 
500 μM hesperidin or 500 μM rutin. After 48 h of anaerobic incubation at 37 °C under gentle agitation, 
cultures were analyzed for rutinosides and aglycones concentrations. As controls, cultures without 
rutinosides and non-inoculated MRS containing 500 μM hesperidin or 500 μM rutin were analyzed after 
48 h of anaerobic incubation at 37 °C. 
Further bioconversion experiments were performed with supernatants and cell extracts from 
Bifidobacterium MRS cultures. Supernatant and biomass were separated by centrifugation (6000× g for 
10 min at 4 °C). The pH of the supernatant was corrected to 6.5, then sterilized through a 0.22 μm filter. 
The biomass was washed twice and resuspended with PBS-Cys, in order to obtain the turbidity of 1.5 AU 
(λ = 600 nm), and subjected to mechanical disruption through one passage at 20.0 kPsi in One Shot Cell 
Disrupter (Constant Systems). The cell extract was clarified by centrifugation (13,000× g for 15 min at 
4 °C), and liquid phase was sterilized through a 0.22 μm filter. 
Supernatants and cell-free extracts were supplemented with 500 μM hesperidin or rutin and  
incubated anaerobically at 37 °C under gentle agitation. After 24 h of incubation, the samples were 
heated at 100 °C for 10 min to stop enzymatic reactions, and analyzed. As controls, supernatants or cell 
extracts without rutinosides, or 500 μM rutinosides in MRS or PBS-Cys were utilized. 
2.4. Fermentation Experiments 
Bioreactor batch processes were performed with B. pseudocatenulatum WC 0403 in 500 mL 
bioreactors (Sixfors V3.01, Infors, Bottmingen, Switzerland), containing 250 mL of MRS supplemented 
with 500 μM hesperidin. The culture was kept at 37 °C under gentle agitation; anaerobic conditions were 
maintained by keeping the medium under a stream of CO2. A pH controller delivered 4 M NaOH to 
prevent the pH falling below 5.5. Samples were collected periodically to measure glucose, hesperetin, 
and hesperidin. 
To study hesperidin bioconversion by the supernatant and cell extracts at different growth phases, 
samples were withdrawn after 8, 24, and 48 h from controlled-pH (5.5) batch cultures. 
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2.5. Analysis of Flavonols and Flavanones 
At the end of the transformation experiments carried out with cultures, supernatants, and cell extracts, 
the bioconversion mixtures were frozen at −80 °C, freeze dried, and extracted with DMSO. The extracts 
were clarified by centrifugation (13,000×g for 5 min at 4 °C) and filtration (0.22 μm) to remove cells 
and/or solids, and analyzed with HPLC to quantify residual rutinosides and the corresponding aglycones. 
One μL was injected into a HPLC device (Agilent 1100, Agilent Technologies Inc., Santa Clara, CA, 
USA) equipped with a ZORBAX Eclipse XDB-C18 column (rapid resolution, 1.8 μm particle size,  
4.6 × 50 mm, Agilent,) and variable wavelength detector coupled with an ESI ion trap mass spectrometer 
(Agilent 1100 LC-MSD trap). The mobile phase was composed of 0.1% (v/v) acetic acid in water 
(solvent A) and 0.1% acetic acid in acetonitrile (solvent B). The flow rate was 0.7 mL/min. The following 
gradient of solvent B was applied: 0–25 min, linear from 10% to 30%; 25–30 min, linear to 50%;  
30–40 min, linear to 100%; 40–47 min, linear to 10%. Rutin, hesperidin, quercetin, and hesperetin were 
recognized based on the retention time (13.5, 17.6, 23.3, and 29.3 min respectively) and the m/z of the 
parent ion. The analytes were quantified at 280 nm using the external standard method, the linearity 
being demonstrated from 10 to 1000 μM (R2 > 0.997). The limits of detection (LOD) of rutin, hesperidin, 
quercetin, and hesperetin were 27, 21, 61, and 43 μM, respectively, calculated as 3·(Sy/x)/b, where Sy/x 
represents the residual standard deviation and b is the slope of the linear calibration. 
2.6. Statistical Analysis 
All values are means of three independent experiments. Means were compared with Student’s t-test. 
Differences were considered statistically significant for p < 0.05. 
3. Results 
3.1. Bioconversion of Rutin and Hesperidin by Resting Cells of Human Gut Microbiota 
The transformation of rutin and hesperidin was observed after 24 h incubation with the resting cells 
of human gut microbiota from nine different healthy volunteers. All the fecal suspensions succeeded in 
releasing quercetin from rutin, with yields ranging from 15% to 38% (Figure 2A). After the incubation, 
the sum of residual rutin and quercetin on molar basis was generally significantly lower than the initial 
rutin concentration, ranging from 18% to 85%. In subjects V3 and V7, rutin got nearly exhausted while 
quercetin did not account for more than 21%, indicating that further biotransformations, other than 
rutinose removal, occurred. Similarly, all the fecal suspensions succeeded in releasing hesperetin, with 
yields ranging from 34% to 53% (Figure 2B). In this case, the recovery of hesperetin and hesperidin was 
high, above the 90% in most of the samples. 
No relationship could be established between the extent of the hydrolysis of rutin and hesperidin  
(R2 < 0.01). 
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Figure 2. Bioconversion of rutin (A) and hesperidin (B) with cells of human gut microbiota. 
Fecal bacteria from nine subjects were suspended in PBS-Cys and incubated anaerobically 
at 37 °C for 24 h in presence of 500 μM rutin or hesperidin. Legend: rutin, grey; quercetin, 
green; hesperidin, orange; hesperetin, yellow. Values are means ± SD, n = 3. 
3.2. Bioconversion of Rutin and Hesperidin by Bifidobacteria 
The ability of bifidobacteria to hydrolyze rutin and hesperidin was investigated on thirty-three human 
strains of Bifidobacterium, belonging to the species B. animalis subsp. animalis, B. animalis subsp. 
lactis, B. bifidum, B. breve, B. catenulatum, B. longum subsp. infantis, B. longum subsp. longum, and 
B. pseudocatenulatum. They all were incapable to transform rutin during 48 h of growth in  
rutin-supplemented MRS (Table 1). Consistently, both the supernatants and the cell extracts of all the 
strains were also inactive towards rutin. Furthermore, when bifidobacteria were cultured in presence of 
quercetin, they all failed to transform this aglycone. 
Unlike rutin, a few strains were capable of hydrolyzing hesperidin to some extent, yielding hesperetin 
(Table 1). This feature was a property of the strains belonging to the species B. catenulatum and 
B. pseudocatenulatum (mean conversion = 12.6%, median = 6%), B. pseudocatenulatum WC 0403 
yielding the highest amount of hesperetin (46% conversion). The strains belonging to the other species 
were unable to release the aglycone, with the exception of B. breve WC 0422. In all the strains, the sum 
of the aglycone, if any, and the residual rutinoside was close to 500 μM. Consistently, when 
bifidobacteria were cultured for 48 h in hesperetin-supplemented medium, the aglycone remained 
unaltered. The supernatants of all the tested bifidobacteria were inactive in hesperidin hydrolysis. Cell 
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extracts of the strains whose culture was active released hesperetin from hesperidin, whereas those of 
the inactive strains did not. 
3.3. Kinetics of Hesperidin Hydrolysis by B. Pseudocatenulatum WC 0403 
B. pseudocatenulatum WC 0403, which exhibited the highest yield of hesperidin hydrolysis, was 
selected for a deeper investigation in bioreactor batch cultures of the transformation kinetics of 
hesperidin. The hydrolysis occurred especially during the growth phase, i.e., during the first 24 h of 
cultivation, when 31% conversion was achieved. During the stationary phase, a minor hesperidin 
conversion was observed, with a 42% final yield after 48 h (Figure 3). 
 
Figure 3. Timecourse of hesperidin hydrolysis in batch cultures of B. pseudocatenulatum 
WC 0403. Legend: cell counts, ○; glucose, ●; hesperidin, ▲; hesperetin, ∆; conversion, ◊. 
The experiment was carried out in triplicate. Data from one of the repetitions are  
reported herein. 
In order to investigate the hydrolytic activity against hesperidin during the different growth phases, 
samples of MRS cultures were collected 8, 24, and 48 h, corresponding to the exponential, early 
stationary, and late stationary phases, respectively. At these time-points, both the extracellular and the 
cell-associated activity were investigated. The supernatants were always incapable of hydrolyzing 
hesperidin (<2.0%), without any statistically significant difference during the course of the fermentation 
(p > 0.05). On the contrary, all the extracts were capable of hydrolyzing hesperidin, confirming that the 
activity is intracellular. Hydrolysis by cell extracts was highest during the exponential phase (p < 0.05), 
albeit the extracts from the early and late stationary phases were still active in hydrolyzing hesperetin 
(Figure 4).  
 
Nutrients 2015, 7 2796 
 
 
Figure 4. Hesperetin production after 24 h incubation of 500 μM hesperidin with the 
supernatants (grey) and the cellular extracts (green) of B. pseudocatenulatum WC 0403. 
Cellular extracts were preliminary normalized to the same cellular concentration. Values are 
means ± SD, n = 3. Within each series, means without a common letter significantly differ 
(p < 0.05). 
4. Discussion 
This study explored the role of gut microbiota and bifidobacteria in the release of the aglycones from 
two major rutinosides, hesperidin and rutin, whose corresponding aglycones hesperetin and quercetin 
present antioxidant, anti-inflammatory, and exert protective effects against cancer and cardiovascular 
diseases [2–4]. 
Rutin and hesperidin were subjected in vitro to the action of resting cells fecal microbiota. The ability 
of the microbiota to remove at some extent the rutinose moiety during 24 h of incubation was evident in 
all the samples. However, despite biotransformations being performed with very dense bacterial 
communities (approx. 1010 cfu/mL, resulting from 1:50 dilution of feces), the complete hydrolysis of 
rutinosides was never obtained. On the other hand, complete hydrolysis of chlorogenic acid was obtained 
in a similar study, in which the phytochemical was incubated with fecal microbiota under the same 
experimental conditions [22]. The disappearance of hesperidin was associated to a stoichiometric 
production of hesperetin, with yields ranging between 34% and 53%. Hydrolysis yields are likely 
affected by the low water solubility of hesperidin. Furthermore, the fact that the transformation of 
hesperetin did not proceed further, indicates that it is a somehow recalcitrant molecule. 
The release of quercetin from rutin was successful in all the samples, with aglycone yields ranging 
from 15% to 58%. In two cases, the sum of quercetin and residual rutin was very low on molar basis, 
with a limited amount of quercetin accumulated in face of the nearly complete disappearance of rutin. 
This evidence can be due to the unlikely removal of the sole rhamnose moiety, or to transformations 
taking place at the expense of the aglycone. Consistently with this latter hypothesis, a previous study 
demonstrated that quercetin is transient in rutin-supplemented fecal cultures, being rapidly subjected to 
ring fission and transformation into hydroxyphenylacetic acid derivatives [25]. 
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Bifidobacteria are important members of the saccharolytic population of intestinal bacteria, being 
able to produce several diverse glycosyl-hydrolases that are necessary to hydrolyze a number of  
oligo- and polysaccharides into fermentable sugars [18,26]. Abundant genomic data of sequenced 
bifidobacteria confirm the remarkable array of genes encoding for glycosyl hydrolases, whose 
involvement in the release of bioactive aglycones from dietary polyphenols has recently been claimed. 
However, the real contribution of Bifidobacterium species in the hydrolysis of specific polyphenols still 
needs to be proven. 
Among the six tested species, mostly B. catenulatum and B. pseudocatenultum were able to hydrolyze 
hesperidin, by means of a cell-associated hydrolytic activity. The strains that were active in culture also 
presented active cell extracts, while the strains that were inactive in culture gave cell extracts that did 
not yield hesperetin. Therefore, among the strains herein tested, the inability of hydrolyzing hesperidin 
was not due to the lack of a suitable transport system. In agreement with the behavior of other  
glyco-conjugated polyphenols such as lignans and soy isoflavones, all the bifidobacteria were incapable 
of carrying out any further biotransformation of the aglycone [20,21]. In fact, for the strains able to 
hydrolyze hesperidin, the amount of hesperidin consumed corresponded to the amount of hesperetin 
yielded. Unlike hesperidin, rutin was utterly resistant to hydrolysis by bifidobacteria. The absence of 
hydrolytic activity in both supernatants and cell extracts established the lack of any glycosyl-hydrolase 
activity able to carry out rutin hydrolysis. 
A previous study by Aura et al., investigating the deglycosylation of cyanidin glycosides, 
demonstrated that rutinose removal from rutinosides requires the intervention of a α-rhamnosidase 
initially, and then of β-glycosidase [27]. The former activity represents the rate limiting step, due to the 
lower levels of α-rhamnosidase within the gut microbiota, while the latter proceeds much more rapidly, 
β-glucosidase being much more abundant [27]. 
An α-L-rhamnosidase capable of hydrolyzing diverse rhamnoglycoside-conjugated phytochemicals 
was recently cloned from Bifidobacterium dentium (GenBank: AGS77942.1) by Bang et al. [28].  
A homologue of this gene can be found in the genome of B. pseudocatenulatum IPLA36007 (GenBank: 
KEF28006.1) [29], whose protein sequence exhibits an identity of 78.99% with the homologue of 
B. dentium. A TBLASTN search revealed that most of the available genome sequences of bifidobacteria, 
aside from B. pseudocatenulatum and B. dentium, do not bear homologues of KEF28006.1 or 
AGS77942.1, the sole exceptions being B. kashiwanohense PV20-2 and B. breve JCM 7019. It is 
interesting that 16 genome sequences are currently available for strains belonging to B. breve and that 
only one bears a gene encoding a putative α-L-rhamnosidase, homologue to those of 
B. pseudocatenulatum and B. dentium. This observation agrees with the result that only one out of 
six strains of B. breve hydrolyzed hesperidin in the present screening. 
5. Conclusions 
The data herein presented demonstrated that B. pseudocatenulatum can hydrolyze certain  
rutinose-conjugated polyphenols, such as hesperidin, thus releasing the aglycone form. Therefore, 
B. pseudocatenulatum may potentially contribute to the bioavailability of this class of molecules.  
However it remains to be clarified whether this species may exert a role in the colonic ecosystem to such 
an extent to effectively improve colonic absorption in vivo. 
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